•
Mar 31, 2024

Ovid Therapeutics Q2 2024 Earnings Report

Total Revenue
$169K
Previous year: $75K
+125.3%
EPS
$0.12
Previous year: -$0.18
-166.7%
Gross Profit
$12K
Previous year: $75M
-100.0%
Cash and Equivalents
$90.3M
Previous year: $96.5M
-6.5%
Free Cash Flow
-$16.7M
Previous year: -$11.7M
+42.6%
Total Assets
$132M
Previous year: $136M
-3.4%

Ovid Therapeutics

Ovid Therapeutics